Skip to main content
SpringerLink
Log in

Association of diabetes with dyskinesia in older psychosis patients

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Older patients treated with antipsychotics are more likely to develop tardive dyskinesia (TD) than younger individuals. Advanced age is also an important risk factor for diabetes, which may be associated with TD. These observations suggest that older diabetic patients may be particularly vulnerable to developing TD.

Objective

To examine whether older psychosis patients with diabetes exhibit more severe dyskinesia than well-matched patients without diabetes and to test whether there are differences in dyskinesia severity between diabetic patients treated with conventional versus atypical antipsychotics versus those not taking antipsychotic medications.

Method

Sixty-one psychosis patients with diabetes and 122 case-matched non-diabetic comparison patients were studied. Observer-based and quantitative instrumental measures were administered to assess prevalence and severity of dyskinesia. Raters were unaware of patients’ diabetes status.

Results

Diabetic patients exhibited significantly more severe TD than non-diabetic comparison patients. Groups did not differ in terms of severity of parkinsonism. Significantly more diabetic (27.9%) than non-diabetic (14.6%) patients met research diagnostic criteria for TD. Diabetic patients treated with atypical antipsychotics at the time of assessment had significantly more severe TD than all other patient subgroups, including patients treated with conventional antipsychotics. Results from the instrumental measures of force steadiness were consistent with observer-based severity ratings.

Conclusion

The deleterious effect of diabetes on TD in the absence of any effect of parkinsonism supports preclinical studies of glucose-related dopamine hyperfunction and has implications for the pharmacologic management of psychosis in patients with pre-existing diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adler CM, Elman I, Weisenfeld N, Kestler L, Pickar D, Breier A (2000) Effects of acute metabolic stress on striatal dopamine release in healthy volunteers. Neuropsychopharmacology 22:545–550

    Article  CAS  PubMed  Google Scholar 

  • Agardh CD, Carlsson A, Linqvist M, Siesjo BK (1979) The effect of pronounced hypoglycemia on monoamine metabolism in rat brain.Diabetes 28:804–809

    CAS  PubMed  Google Scholar 

  • American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders 4th edn. APA, Washington D.C.

  • Caligiuri MP, Lohr JB (1991) Fine force instability: a quantitative measure of hand dyskinesia. J Neuropsychiatr Clin Neurosci 2:395–398

    Google Scholar 

  • Caligiuri MP, Lohr JB, Rotrosen J, et al (1997) Reliability of an instrumental measure of tardive dyskinesia: experience of a multicenter study. Psychopharmacology 132:61–66

    Article  CAS  PubMed  Google Scholar 

  • Chang AM, Halter JB (2003) Aging and insulin secretion. Am J Physiol Endocrinol Metab 284:E7–E12

    CAS  PubMed  Google Scholar 

  • Dolder CR, Jeste DV (2003) Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high-risk patients. Biol Psychiatry 5:1142–1145

    Article  Google Scholar 

  • During MJ, Leone P, Davis KE, Kerr D, Sherwi RS (1995) Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels. J Clin Invest 95:2403–2408

    CAS  PubMed  Google Scholar 

  • Folstein MF, Folstein SE, Mchugh PR (1975) “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

    CAS  PubMed  Google Scholar 

  • Ganzini L, Heintz R, Hoffman W, Casey D (1991) The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. Arch Gen Psychiatry 48:259–263

    CAS  PubMed  Google Scholar 

  • Guy W, Psychopharmacology Research Branch, NIMH (1976) Abnormal involuntary movement scale (AIMS), in ECDEU assessment manual for psychopharmacology, revised. Publication ADM 76–338. National Institute of Mental Health, Rockville, pp 534–537

  • Hamilton M (1960) Rating depressive patients. J Clin Psychiatry 41:21–24

    Google Scholar 

  • Ifergane G, Masalha R, Herishanu YO (2001) Transient hemichorea/hemiballismus associated with new onset hyperglycemia. Can J Neurol Sci 28:365–368

    CAS  PubMed  Google Scholar 

  • Jeste DV, Caligiuri MP, Paulsen JS, Heaton RK, Lacro JP, Harris MJ, Bailey A, Fell RL, McAdams LA (1995) Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients. Arch Gen Psychiatry 52:756–765

    CAS  PubMed  Google Scholar 

  • Jeste DV, Lacro JP, Bailey A, Rockwell E, Harris MJ, Caligiuri MP (1999). Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc 47:716–719

    CAS  PubMed  Google Scholar 

  • Levin BE (2000) Glucose-regulated dopamine release from substantia nigra neurons. Brain Res 874:158–164

    CAS  PubMed  Google Scholar 

  • Lindenmayer JP, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M, Lieberman JA (2003) Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Am J Psychiatry 160:290–296

    Article  PubMed  Google Scholar 

  • Lozoversusky D, Saller CF, Kopin IJ (1981) Dopamine receptor binding is increased in diabetic rats. Science 214:1031–1033

    PubMed  Google Scholar 

  • Lozoversusky D, Kopin IJ, Saller CF (1985) modulation of dopamine receptor supersensitivity by chronic insulin: implication in schizophrenia. Brain Res 343:190–193

    Article  PubMed  Google Scholar 

  • Mattis S (1988) Dementia rating scale professional manual. Psychological Assessment Resources, Inc., Odessa, Fla.

  • Mouret J, Khomais M, Lemoine P, Serbet P (1991) Low doses of insulin as a treatment of tardive dyskinesia: conjuncture or conjecture? Eur Neurol 31:199–203

    CAS  PubMed  Google Scholar 

  • Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799–812

    Google Scholar 

  • Roper J, Ashcroft FM (1995) Metabolic inhibition and low internal ATP activate KATP channels in rat dopaminergic substantia nigra neurons. Pflugers Arch 430:44–54

    CAS  PubMed  Google Scholar 

  • Saller CF (1984) Dopaminergic activity is reduced in diabetic rats.Neurosci Lett 49:301–306

    Article  CAS  PubMed  Google Scholar 

  • Saller CF, Chiodo LA (1980) Glucose suppresses basal firing and haloperidol-induced increases in the firing rate of central dopaminergic neurons. Science 210:1269–1271

    CAS  PubMed  Google Scholar 

  • Schooler NR, Kane JM (1982) Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 39:486–487

    CAS  Google Scholar 

  • Schultz SK, Arndt S, Ho B-C, Oliver SE, Andreasen NC (1999) Impaired glucose tolerance and abnormal movements in patients with schizophrenia. Am J Psychiatry 156:640–642

    CAS  PubMed  Google Scholar 

  • Simpson G, Angus JWS (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212:11–19

    CAS  PubMed  Google Scholar 

  • Wirshing DA, Boyd JA, Meng LR, Ballon JS, Marder SR, Wirshing WC (2002) The effects of novel antipsychotics on glucose and lipid levels. J Clin Psychiatry 63:856–865

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This research was supported, in part, by USPHS grants from NIMH (1 P30 MH66248-02 and 5 R01 MH59191-05), and the Department of Veteran Affairs VISN-22 MIRECC. This study complied with the current US laws governing research involving human subjects. The authors acknowledge no conflict of interest, financial or otherwise, involving any of the pharmaceutical companies whose products were described in this study.

Author information

Authors and Affiliations

  1. Department of Psychiatry (0603), School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA

    Michael P. Caligiuri

  2. Department of Veterans Affairs Medical Center, San Diego, Calif., USA

    Dilip V. Jeste

Authors
  1. Michael P. Caligiuri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dilip V. Jeste
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael P. Caligiuri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caligiuri, M.P., Jeste, D.V. Association of diabetes with dyskinesia in older psychosis patients. Psychopharmacology 176, 281–286 (2004). https://doi.org/10.1007/s00213-004-1893-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-004-1893-8

Keywords

Search

Navigation